Company profile: Confo Therapeutics
1.1 - Company Overview
Company description
- Provider of GPCR-focused drug discovery solutions leveraging proprietary Confo® Technology and conformationally selective VHH ConfoBodies® to stabilize GPCRs in active, disease-relevant states. Offerings include ConfoScreen®, ConfoSensor®, and ConfoStructure™ for screening, biosensing, and structure-based design, and MegaBody™ for high-resolution cryo-EM, enabling novel medicine discovery and internal programs addressing unmet medical need.
Products and services
- Confo® Technology: Conformationally selective platform employing VHH ConfoBodies to lock unstable functional GPCR conformations in disease-relevant active states, expediting discovery of novel medicines targeting dynamic membrane proteins
- ConfoStructure™: Structure-based technology determining three-dimensional active-state GPCR structures to support rational design of optimal compounds, enabling precise drug discovery campaigns on target receptors
- ConfoBodies®: Single-domain VHH antibodies that bind and stabilize GPCRs in their active state, aiding drug discovery for dynamic membrane proteins
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Confo Therapeutics
Avivia
HQ: The Netherlands
Website
- Description: Provider of pharmaceutical CRO services, including analytical testing, drug formulation, generic drugs, repurposing, and troubleshooting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avivia company profile →
Facet Biotech
HQ: United States
Website
- Description: Provider of biotechnology research and development focused on identifying and developing oncology drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Facet Biotech company profile →
Herborium
HQ: United States
Website
- Description: Provider of botanical therapeutics that develops, licenses, and markets proprietary botanical-based medicinal products. Offerings include AcnEase, a herbal acne and rosacea treatment; the Virtual Institute for Natural and Complementary Medicine, an educational platform for integrative medicine; the Kamasutra Spirits product line; and Herborium Botanical Therapeutics addressing dermatological needs and sexual disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Herborium company profile →
Ablynx
HQ: Belgium
Website
- Description: Provider of a proprietary Nanobody® technology platform for the discovery and development of therapeutic nanobodies—small single-domain antibody fragments—targeting serious human diseases including inflammation, haematology, oncology and pulmonary disease, with approximately 25 projects in the pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ablynx company profile →
United Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology products and patient support services, including an Expanded Access Program for investigational drugs; ASSIST Access Solutions for medicine access and financial assistance; Archways educational resources for patients on inhaled or oral treprostinil via phone or video; and MyOldMeds.com for secure storage and disposal of unwanted or expired medications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full United Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Confo Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Confo Therapeutics
2.2 - Growth funds investing in similar companies to Confo Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Confo Therapeutics
4.2 - Public trading comparable groups for Confo Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →